FDA Grants Breakthrough Device Status For MediBeacon’s Transdermal GFR Measurement System
Nov 28, 2018 @ 10:10

"The U.S. Food and Drug Administration (FDA) has granted Breakthrough Device designation to the company’s Transdermal GFR Measurement System (TGFR). The device is intended to measure Glomerular Filtration Rate (GFR) in patients with impaired or normal renal function."

Sourced through Scoop.it from: www.mpo-mag.com

Leave a Reply